Abstract:Previously, we have reported that siRNA-mediated survivin inhibition could enhance in vitro chemo- or radiosensitivity of colorectal cancer (CRC) cells. The aim of this study was to investigate whether that small interfering RNA (siRNA) targeting survivin could enhance in vivo chemo- or radiosensitivity of colorectal cancer cells.pSilencer4.1-shRNA targeting survivin (pSilencer4.1-s) and pSilencer4.1-NC (negative control) vectors were previously constructed by us. Two colorectal cancer cell lines (LoVo or HCT-8) were collected and used for forming subcutaneous tumors in nude mice. Then, the tumors were intratumorally injected with pSilencer4.1-s or pSilencer4.1-NC vectors combined with chemotherapy (5-FU) or radiotherapy (6Gy). Firstly, the expression of survivin mRNA and protein in tumors treated with pSilencer4.1-s or pSilencer4.1-NC alone was detected by RT-PCR and Western blotting or immunohistochemistry assays. Next, the tumor volumes were recorded. The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay was performed to detect apoptosis of tumor cells and the activity of caspase-3 was detected.The expression of survivin mRNA and protein in tumor tissues treated with pSilencer4.1-s was significantly downregulated (p < 0.05). The immunostaining of survivin protein was also significantly weaker in tumor tissues treated with pSilencer4.1-s. Moreover, the volumes of the nude mice treated with pSilencer4.1-s and chemo- or radiotherapy decreased markedly compared with those of the mock- or pSilencer4.1NC-treated control combined with chemo- or radiotherapy. The apoptosis of tumor tissue cells treated with pSilencer4.1-s and chemo- or radiotherapy could be significantly increased compared with the mock- or pSilencer4.1-NC-treated control combined with chemo- or radiotherapy (p < 0.05), which might be associated with the active Caspase-3 pathway.siRNA-mediated survivin inhibition could enhance in vivo chemo- or radiosensitivity of CRC cells. Accordingly, the survivin gene might be a potential target for the chemoradiotherapy of CRC.

Bcl-xL DNAzymes Promote Radiosensitivity and Chemosensitivity in Colorectal Cancer Cells Via Enhancing Apoptosis.

Suppressing the growth of rectal cancer xenografts derived from patient tumors by an adenovector expressing small hairpin RNA targeting Bcl-XL.

Adenovirus-Mediated Small Hairpin Rna Targeting Bcl-Xl As Therapy For Colon Cancer

Adenovirus-mediated Sirna Targeting Bcl-xL Inhibits Proliferation, Reduces Invasion and Enhances Radiosensitivity of Human Colorectal Cancer Cells.

Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer

Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis

Bcl-Xl Small Interfering Rna Suppresses The Proliferation Of 5-Fluorouracil-Resistant Human Colon Cancer Cells

Downregulation of CDC20 Increases Radiosensitivity through Mcl-1/p-Chk1-Mediated DNA Damage and Apoptosis in Tumor Cells.

Deoxyribozymes targeted to EBV-LMP1 mRNA induce apoptosis and enhance radiosensitivity in LMP1-positive cells

shRNA-mediated XRCC2 gene knockdown efficiently sensitizes colon tumor cells to X-ray irradiation in vitro and in vivo.

Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells.

Chemotherapy and radiotherapy downregulate the activity and expression of DNA methyltransferase and enhance Bcl-2/E1B-19-kDa interacting protein-3-induced apoptosis in human colorectal cancer cells.

Bcl-XL Sirna Sensitizes Human MGC-803 Gastric Cancer Cells to 5-Fluorouracil and Diallyl Disulfide

Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer

Enhancing the radiosensitivity of colorectal cancer cells by reducing spermine synthase through promoting autophagy and DNA damage

Bcl-XL Small Interfering RNA Sensitizes Cisplatin-resistant Human Lung Adenocarcinoma Cells

Knockdown of DNA‐binding Protein A Enhances the Chemotherapy Sensitivity of Colorectal Cancer Via Suppressing the Wnt/β‐catenin/Chk1 Pathway

Anti-K-ras ribozyme induces growth inhibition and increased chemosensitivity in human colon cancer cells

Modification of BCLX pre-mRNA splicing has antitumor efficacy alone or in combination with radiotherapy in human glioblastoma cells

Enhanced Chemosensitivity by Simultaneously Inhibiting Cell Cycle Progression and Promoting Apoptosis of Drug-Resistant Osteosarcoma Mg63/Dxr Cells by Targeting Cyclin D1 and Bcl-2

SiRNA-mediated Survivin Inhibition Enhances Chemo- or Radiosensivity of Colorectal Cancer Cells in Tumor-Bearing Nude Mice.